Cohance Lifesciences' promoter Jusmiral Holdings Limited has sold 3.41 Cr equity shares, reducing its stake from 33.08% to 24.15%. This transaction 'releases' previous restrictions (covenants) on these shares.

Proceeds from the sale will mainly be used to partly repay existing borrowings.

It's important for investors to note that Jusmiral Holdings Limited itself had not directly pledged its shares in Cohance Lifesciences; instead, its parent company had pledged its shares in Jusmiral Holdings Limited.